Oryzon Genomics SA
MAD:ORY

Watchlist Manager

Oryzon Genomics SA

MAD:ORY

Watchlist

Dividends

Discount Rate

Price: 1.558 EUR -0.76% Market Closed

Market Cap: 99.4m EUR

Have any thoughts about
Oryzon Genomics SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 1.558 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ORY Alert

Oryzon Genomics SA

1.558

-0.012 (-0.76%)

52 Week Range	1.558 2.215
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Oryzon Genomics SA

What unique competitive advantages
does Oryzon Genomics SA hold over its rivals?

What risks and challenges
does Oryzon Genomics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Oryzon Genomics SA.

What unique competitive advantages
does Oryzon Genomics SA hold over its rivals?

What risks and challenges
does Oryzon Genomics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Oryzon Genomics SA.

Provide P/S
for Oryzon Genomics SA.

Provide P/E
for Oryzon Genomics SA.

Provide P/OCF
for Oryzon Genomics SA.

Provide P/FCFE
for Oryzon Genomics SA.

Provide P/B
for Oryzon Genomics SA.

Provide EV/S
for Oryzon Genomics SA.

Provide EV/GP
for Oryzon Genomics SA.

Provide EV/EBITDA
for Oryzon Genomics SA.

Provide EV/EBIT
for Oryzon Genomics SA.

Provide EV/OCF
for Oryzon Genomics SA.

Provide EV/FCFF
for Oryzon Genomics SA.

Provide EV/IC
for Oryzon Genomics SA.

Show me price targets
for Oryzon Genomics SA made by professional analysts.

What are the Revenue projections
for Oryzon Genomics SA?

How accurate were the past Revenue estimates
for Oryzon Genomics SA?

What are the Net Income projections
for Oryzon Genomics SA?

How accurate were the past Net Income estimates
for Oryzon Genomics SA?

What are the EPS projections
for Oryzon Genomics SA?

How accurate were the past EPS estimates
for Oryzon Genomics SA?

What are the EBIT projections
for Oryzon Genomics SA?

How accurate were the past EBIT estimates
for Oryzon Genomics SA?

Compare the revenue forecasts
for Oryzon Genomics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Oryzon Genomics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Oryzon Genomics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Oryzon Genomics SA compared to its peers.

Compare the P/E ratios
of Oryzon Genomics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Oryzon Genomics SA with its peers.

Analyze the financial leverage
of Oryzon Genomics SA compared to its main competitors.

Show all profitability ratios
for Oryzon Genomics SA.

Provide ROE
for Oryzon Genomics SA.

Provide ROA
for Oryzon Genomics SA.

Provide ROIC
for Oryzon Genomics SA.

Provide ROCE
for Oryzon Genomics SA.

Provide Gross Margin
for Oryzon Genomics SA.

Provide Operating Margin
for Oryzon Genomics SA.

Provide Net Margin
for Oryzon Genomics SA.

Provide FCF Margin
for Oryzon Genomics SA.

Show all solvency ratios
for Oryzon Genomics SA.

Provide D/E Ratio
for Oryzon Genomics SA.

Provide D/A Ratio
for Oryzon Genomics SA.

Provide Interest Coverage Ratio
for Oryzon Genomics SA.

Provide Altman Z-Score Ratio
for Oryzon Genomics SA.

Provide Quick Ratio
for Oryzon Genomics SA.

Provide Current Ratio
for Oryzon Genomics SA.

Provide Cash Ratio
for Oryzon Genomics SA.

What is the historical Revenue growth
over the last 5 years for Oryzon Genomics SA?

What is the historical Net Income growth
over the last 5 years for Oryzon Genomics SA?

What is the current Free Cash Flow
of Oryzon Genomics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Oryzon Genomics SA.

EV/OCF
Enterprise Value to OCF

-50.7

Current

-180.6

Median

5.7

Industry

Higher than median

Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF

-50.7

Enterprise Value

95.9m EUR

Operating Cash Flow

-1.9m EUR

All Countries

Forward Multiples

			Market Cap	EV/OCF
ES		Oryzon Genomics SA MAD:ORY	98.1m EUR	-50.7
FR		Pharnext SCA OTC:PNEXF	6T USD	-239 317.7
US		Abbvie Inc NYSE:ABBV	312.7B USD	22
US		Amgen Inc NASDAQ:AMGN	158.3B USD	28.4
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	116.2B USD	-128.8
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	10.7
US	E	Epizyme Inc F:EPE	94.1B EUR	-470.5
AU		CSL Ltd ASX:CSL	133.6B AUD	34.9
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	81.3B USD	17.5
US	S	Seagen Inc F:SGT	39.3B EUR	-73.6
NL		argenx SE XBRU:ARGX	34.8B EUR	-128


ES		Oryzon Genomics SA MAD:ORY	Average EV/OCF: 22.7 Negative Multiple: -50.7
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -239 317.7
US		Abbvie Inc NYSE:ABBV	22
US		Amgen Inc NASDAQ:AMGN	28.4
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -128.8
US		Gilead Sciences Inc NASDAQ:GILD	10.7
US	E	Epizyme Inc F:EPE	Negative Multiple: -470.5
AU		CSL Ltd ASX:CSL	34.9
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	17.5
US	S	Seagen Inc F:SGT	Negative Multiple: -73.6
NL		argenx SE XBRU:ARGX	Negative Multiple: -128

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/OCF

N/A

2-Years Forward

EV/OCF

N/A

3-Years Forward

EV/OCF

N/A

Oryzon Genomics SA
MAD:ORY

EV/OCF
Enterprise Value to OCF

EV/OCF Forward Multiples

See Also

Company

Help

Tools

Stocks

Oryzon Genomics SA MAD:ORY

EV/OCF Enterprise Value to OCF

EV/OCF Forward Multiples

See Also

Company

Help

Tools

Stocks

Oryzon Genomics SA
MAD:ORY

EV/OCF
Enterprise Value to OCF